Antibiotics were appropriate if active in vitro against isolated GN. Optimal antibiotics were not overly broad, accounted for resistance, source of infection, and other infecting organisms. Comparisons were made using Chisquared for nominal variables and Kaplan-Meier with log-rank for time to event analysis.
Background. Increased mean platelet volume (MPV) is a marker of more active and rapidly aggregating platelets. There is limited evidence that increased MPV is associated with more embolic disease in infectious endocarditis (IE). This study seeks to validate this relationship and assess for effect modification by injection drug use.
Methods. Records of all patients aged ≥18 admitted to Wake Forest Baptist Medical Center (WFBMC) from January 1, 2004 to September 30, 2015 with an ICD-9 code for IE and without a simultaneous ICD-9 code indicating"mechanical complication of cardiac device, implant and graft' were reviewed. Inclusion criteria consisted of possible or definite IE by modified Duke criteria and labs drawn within 24 hours of presentation. Univariate analyses were assessed by Chi-square, Fisher's exact test, Mann-Whitney U, and Student's t-test. Multiple logistic regression assessed the association between MPV and embolic phenomena while controlling for potential confounders.
Results. A total of 237 cases (80 IDU-IE and 157 non-IDU IE) met criteria for analysis suffering 115 (48.5%) embolic events to the brain and/or lungs (41.4% in non-IDU vs. 62.5% in IDU-IE, P = 0.002). MPV (P < 0.0001) and drug use (P = 0.002) were significantly associated with embolic disease. S aureus involvement (P = 0.0002), vegetation ≥1 cm (P = 0.009), atrial fibrillation (P = 0.05), hypertension (P = 0.05), age (P = 0.0008), presenting hospital location (P = 0.001), total platelets (P < 0.0001), age-unadjusted Charleson comorbidity score (P = 0.001), and left-sided valve vegetation (P = 0.006) were also significantly associated while gender, white blood cell count, creatinine and albumin were not. MPV remained significantly associated with embolic disease in the fully adjusted model with OR 1.4, 95% CI [1.1-1.7]. Vegetation ≥1 cm (OR 2.4, 95% CI [1.2-4.7]), left-sided valve vegetation (OR 0.4, 95% CI [0.2-0.8]) and direct presentation rather than transfer to WFBMC (OR 0.4, 95% CI [0.2-0.8]) also remained significant. There was no evidence of an interaction between MPV and drug use nor evidence of effect modification when the analysis was stratified by drug use status.
Conclusion. Increased MPV is significantly associated with embolic disease of IE even when additional covariates are taken into consideration.
Disclosures. All authors: No reported disclosures. Background. Along with a growing opioid epidemic nationwide, opioid users often have an increased risk of severe infectious diseases including endocarditis, osteomyelitis, and central nervous system (CNS) abscess. As the largest city in the United States, New York City (NYC) may serve as a study model for opioid use and infectious diseases. We investigated the association between opioid use and hospitalizations for endocarditis, osteomyelitis, and CNS abscess in NYC.
Opioid Use and Hospitalizations for Endocarditis, Osteomyelitis, and Central Nervous System Abscess among Adults -New
Methods. Data for NYC residents aged ≥18 years discharged from New York State hospitals during 2001-2014 were analyzed using a hospital discharge dataset. We defined a hospitalization for endocarditis, osteomyelitis, and CNS abscess as one with a principal or secondary diagnosis for these conditions within the discharge record. We identified opioid users by examining principal or secondary diagnoses for opioid use within the discharge record at the time of hospitalization for endocarditis, osteomyelitis, and CNS abscess. Logbinomial model was applied among all hospitalized patients using endocarditis, osteomyelitis, and CNS abscess as the outcome, adjusting for age, sex, race, and borough.
Results. During 2001-2014, there were 139,392 hospitalizations in total for endocarditis, osteomyelitis, or CNS abscess, of which 8,823 (6.3%) were among opioid users. There was an increased risk of hospitalization for endocarditis [RR: 2.6 (95% CI: 2.5-2.7)], osteomyelitis [RR: 1.1 (95% CI: 1.1-1.1)], and CNS abscesses [RR: 1.9 (95% CI: 1.8-2.1)] among hospitalized opioid users compared with hospitalized nonopioid users, adjusted by age, sex, race, and borough. Hospitalized opioid users had four times the risk for endocarditis hospitalization compared with hospitalized nonopioid users in the 18-44 year age group (RR: 4.2 [95% CI: 3.9-4.5]) (Table 1) .
Conclusion. These results provide further evidence that opioid use is associated with an increased risk of endocarditis, osteomyelitis, and CNS abscess. Efforts to combat the opioid epidemic might lower the overall incidence of endocarditis, osteomyelitis, and CNS abscess.
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Organism Identification and Antibiotic Susceptibilities with Verigene Blood Culture Assay: a Retrospective Single-Center Study
Stephanie Tchen, PharmD 1 ; Steven Smoke, PharmD 2 and Maria DeVivo, PharmD, MPA 2 ; 1 Community Medical Center, Toms River, New Jersey; 2 Jersey City Medical Center, Union, New Jersey Session: 37. Bacteremia, CLABSI, and Endovascular Infections Thursday, October 3, 2019: 12:15 PM Background. The Verigene blood culture assay is a rapid molecular testing platform for positive blood cultures. Verigene detects a limited number of bacteria and a limited number of antibiotic resistance determinants. While certain Verigene results have clear implications for optimal antibiotic therapy prior to complete antibiotic susceptibility testing, others do not. The purpose of this study was to compare the results of the Verigene blood culture assay with standard organism identification and antibiotic susceptibility testing.
Methods. This was a retrospective cohort study conducted at a single academic medical center. The study period was 14 months from November 2017 to December 2018. All Verigene results from the study period were reviewed and compared with the results of standard organism identification and susceptibility testing. Organism identification and antibiotic susceptibility testing were performed by Vitek MS and Vitek 2. Duplicate results from the same patient were excluded. The primary outcome was the percentage of blood cultures correctly identified by Verigene. Secondary outcomes included the antibiotic susceptibility of organisms identified by Verigene in the presence and absence of resistance determinants and the identity and frequency of organisms not detected by Verigene.
Results. A total of 782 Verigene results were screened. After exclusions, 675 Verigene results including 737 organisms from 597 patients were included. Of 737 organisms, Verigene correctly identified 611 (82.9%), incorrectly identified 19 (2.6%) and was unable to identify 107 (14.5%) off-panel organisms. Tables 1 and 2 outline the antibiotic susceptibility of organisms by the presence or absence of resistance determinants in Gram-negative and Gram-positive bacteria, respectively. Table 3 describes the identities of the organisms not detected by Verigene, stratified by Gram stain result.
Conclusion. The Verigene blood culture assay demonstrated accuracy in identifying organisms and predicting antibiotic susceptibility. These results will help inform the prospective interpretation of Verigene results and subsequent antibiotic selection at the study institution.
